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ABSTRACT
The term “nonsense-mediated mRNA decay” (NMD) originally described the degradation of mRNAs with premature translation–
termination codons (PTCs), but its meaning has recently been extended to be a translation-dependent post-transcriptional
regulator of gene expression affecting 3%–10% of all mRNAs. The degradation of NMD target mRNAs involves both
exonucleolytic and endonucleolytic pathways in mammalian cells. While the latter is mediated by the endonuclease SMG6,
the former pathway has been reported to require a complex of SMG5–SMG7 or SMG5–PNRC2 binding to UPF1. However, the
existence, dominance, and mechanistic details of these exonucleolytic pathways are divisive. Therefore, we have investigated
the possible exonucleolytic modes of mRNA decay in NMD by examining the roles of UPF1, SMG5, SMG7, and PNRC2 using
a combination of functional assays and interaction mapping. Confirming previous work, we detected an interaction between
SMG5 and SMG7 and also a functional need for this complex in NMD. In contrast, we found no evidence for the existence of
a physical or functional interaction between SMG5 and PNRC2. Instead, we show that UPF1 interacts with PNRC2 and that it
triggers 5′–3′ exonucleolytic decay of reporter transcripts in tethering assays. PNRC2 interacts mainly with decapping factors
and its knockdown does not affect the RNA levels of NMD reporters. We conclude that PNRC2 is probably an important
mRNA decapping factor but that it does not appear to be required for NMD.
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INTRODUCTION
The nonsense-mediated mRNA decay pathway (NMD) is
best known as a post-transcriptional surveillance pathway
that specifically identifies and degrades mRNAs containing
a premature translation-termination codon (PTC) and hence
prevents the build-up of potentially harmful truncated pro-
teins (Lykke-Andersen and Jensen 2015; Hug et al. 2016;
Karousis et al. 2016). Messenger RNAs may contain PTCs
due to nonsense or frame-shift mutations, transcriptional er-
rors, gene rearrangements, or alternative splicing (Nicholson
et al. 2010). In mammalian cells, one-third of alternatively
spliced transcripts have PTCs and are substrates for NMD
(Lewis et al. 2003). However, in recent years it has been found
that NMD controls a larger and more diverse inventory of
transcripts than previously thought. Various genome-wide
studies in S. cerevisiae, D. melanogaster, and human cells
showed that 3%–10% of all mRNAs are regulated by the
NMD factor Up-frame shift 1 (UPF1), most of them lacking
a PTC (He et al. 2003; Mendell et al. 2004; Rehwinkel et al.
2005; Colombo et al. 2017), which signifies a role for NMD
as a translation-dependent post-transcriptional regulator of
gene expression.
Past and current research aimed at elucidating the mecha-
nism of NMD led to the structural and functional character-
ization of many of the factors involved in NMD and to how
these factors interact with each other on the target mRNA
during the process of NMD (Kervestin and Jacobson 2012;
Llorca 2012; Schweingruber et al. 2013). A working model
that has emerged from all of this information proposes that
the decision of whether NMD is executed or not depends
on a kinetic competition between activation of UPF1, a
core NMD factor which has 5′–3′ helicase and nucleic acid-
dependent ATPase activities (Bhattacharya et al. 2000), and
efficient translation termination and recycling of the ribo-
somal subunits to the 5′ end of the mRNA in a process that
involves cytoplasmic poly(A)-binding protein (PABP), eu-
karyotic release factor 3 (eRF3), and eukaryotic initiation3These authors contributed equally to this work.
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factor 4G (eIF4G) (Czaplinski et al. 1998; Eberle et al. 2008;
Ivanov et al. 2008; Silva et al. 2008; Singh et al. 2008; Fatscher
et al. 2014; Joncourt et al. 2014). In mammals, degradation of
NMD-targeted mRNAs involves both exonucleolytic and en-
donucleolytic pathways (Schweingruber et al. 2013). The dif-
ferent decay routes all seem to require phosphorylated UPF1
(P-UPF1), which has been shown to interact with the known
downstream effectors SMG6, heterodimeric SMG5–SMG7
and Proline-Rich Nuclear Receptor Coactivator 2 (PNRC2)
(Cho et al. 2009; Okada-Katsuhata et al. 2012; Jonas et al.
2013). SMG5, SMG6, and SMG7 are related proteins that
each contain tetratricopeptide (TPR) domains which form
well-conserved phosphoserine binding sites similar to those
found in 14-3-3-like proteins (Fukuhara et al. 2005; Jonas
et al. 2013). SMG6 and SMG7 have been experimentally con-
firmed to bind phosphorylated threonine 28 and serine 1096
of UPF1, respectively (Fukuhara et al. 2005; Okada-Katsu-
hata et al. 2012; Chakrabarti et al. 2014; Nicholson et al.
2014) and SMG5, SMG6, and SMG7 are thought to promote
dephosphorylation of UPF1 by recruiting protein phospha-
tase 2A (Yamashita 2013). The phosphorylation–dephos-
phorylation cycles are essential for NMD in metazoans and
appear to be coordinated with the UPF1 ATPase activity,
because ATPase deficient UPF1 accumulates in a hyperphos-
phorylated form which possibly prevents translation reini-
tiating on the NMD mRNP (Page et al. 1999; Ohnishi et al.
2003; Kashima et al. 2006; Isken et al. 2008).
SMG6 is a NMD-specific endonuclease that cleaves
mRNAs in the vicinity of the PTC using its C-terminal PIN
(PilT N terminus) domain (Glavan et al. 2006; Huntzinger
et al. 2008; Eberle et al. 2009). SMG6 endonuclease activity
depends on SMG1 and UPF1 and requires both the binding
of SMG6 to P-UPF1 as well as a phosphorylation-indepen-
dent interaction between SMG6 and the helicase and SQ do-
mains of UPF1 (Okada-Katsuhata et al. 2012; Chakrabarti
et al. 2014; Nicholson et al. 2014).
SMG5 and SMG7 form a heterodimer predominately via
their 14-3-3-like domains interacting in an atypical perpen-
dicular back-to-back orientation (Jonas et al. 2013). The
ability of this complex to degrade mRNA seems to lie in
the C terminus of SMG7, which was shown to recruit the
CCR4-NOT deadenylase complex by specifically interacting
with the catalytic subunit 8 of the CCR4-NOT transcription
complex (CNOT8, also known as POP2) (Loh et al. 2013).
Moreover, the tethered C terminus of SMG7 promoted re-
porter mRNA decay in a decapping enzyme homolog 2
(DCP2) and 5′-3′ exoribonuclease 1 (XRN1) dependent
manner (Unterholzner and Izaurralde 2004). Thus, it is
thought that binding of SMG5–SMG7 to P-UPF1 induces
deadenylation-dependent decapping followed by 5′–3′ degra-
dation of NMD targets (Unterholzner and Izaurralde 2004;
Loh et al. 2013).
Besides binding to SMG7, SMG5 has also been reported to
form a complex with PNRC2 and UPF1 to bring about deg-
radation of NMD substrates by virtue of the fact that PNRC2
can bind to decapping mRNA enzyme 1A (DCP1A) (Albers
et al. 2005; Cho et al. 2009, 2013; Lai et al. 2012). Specifically,
structural and interaction mapping studies have shown that
the proline rich region of PNRC2 interacts with the EVH1
domain of DCP1a and that the NR box located in the C ter-
minus of PNRC2 interacts with P-UPF1 (Lai et al. 2012).
Accordingly, it has been proposed that P-UPF1 binds
SMG5–PNRC2, which in turn recruits DCP1A, and this me-
diates decapping and presumably 5′–3′ degradation of NMD
targets. To date, it is not known which phosphorylated resi-
dues of UPF1 are involved in the binding of SMG5–PNRC2.
Furthermore, it has been reported that this complex is func-
tionally dominant compared to the SMG5–SMG7 in mam-
malian NMD, since SMG5 was reported to preferentially
complex with PNRC2 and UPF1 over SMG7 and UPF1
(Cho et al. 2013). However, this dominance of the
PNRC2–SMG5-mediated NMD mode was challenged by re-
porting the absence of a detectable interaction between
PNRC2 and SMG5 (Loh et al. 2013) and thus its functional
dominance over the SMG5–SMG7-mediated NMD pathway
is unclear and requires further investigation.
In the present study, we have examined the roles of SMG5,
SMG7, and PNRC2 with regard to their interacting proteins
and their function in degrading mRNA. We could neither
detect an interaction between SMG5 and PNRC2 nor find
any evidence for SMG5, PNRC2, and UPF1 working together
to induce mRNA decay in tethered function assays. Rather,
tethered SMG5 predominantly depends on SMG7 to induce
mRNA decay, and we clearly observed an interaction between
these two proteins. Moreover, we confirmed the reported in-
teraction between UPF1 and PNRC2 and provide evidence
that tethered UPF1 requires PNRC2 to induce decapping fol-
lowed by 5′–3′ exonucleolytic mRNA decay. However, this
pathway does not appear to be required for NMD in vivo
because NMD reporter transcript levels were unaffected in
PNRC2 knockdown cells. Collectively, our data suggest that
PNRC2 is a constituent of the general decapping complex
that does not seem to have a specific function in NMD, while
UPF1 seems to be an important universal mRNA degradation
factor that is essential for NMD, but not exclusive to NMD.
Therefore, our data emphasize the need for a commonly
agreed upon definition of NMD, which ultimately may
turn out to be a combination of several different, yet overlap-
ping mechanisms that all result in reduced levels of a specific
subset of mRNAs.
RESULTS
Tethering of SMG5, SMG7, PNRC2, and UPF1 all induce
a strong reduction of reporter mRNA
To further our understanding of the role of UPF1, SMG5,
SMG7, and PNRC2 in the degradation of NMD substrates,
we set up a tethered function assay (TFA) as shown in
Figure 1A (see Nicholson et al. 2012 for a detailed
Nicholson et al.
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description). Full-length SMG5, SMG7, PNRC2, and UPF1,
and a fragment of LacZ serving as a control, were fused to
the MS2 coat protein. The indicated MS2-fusion proteins
were coexpressed with a β-globin reporter mRNA containing
six MS2 binding sites in its 3′UTR (β-globin-6xMS2bs) and a
GFP expressing plasmid in HeLa cells, and the steady-state
levels of the reporter mRNA were quantified and normalized
to the levels of GFP mRNA (Fig. 1B; Supplemental Table S1
for P-values). Expression of SMG5 and SMG7-MS2-fusion
proteins strongly reduced the steady-state levels of the report-
er mRNA levels to below 10% compared to cells expressing
the LacZ-MS2 or the MS2-LacZ controls, which encode a
fragment of LacZ fused to a C-terminally or an N-terminally
located MS2 moiety, respectively. Similarly, expression of
MS2-UPF1 or MS2-PNRC2 fusion proteins also strongly re-
duced the reporter mRNA levels to 12% and 18%, respective-
ly. These results confirm previous TFAs conducted with
UPF1 (Lykke-Andersen et al. 2000; Chiu et al. 2003; Cho et al.
2009, 2013), PNRC2 (Cho et al. 2009, 2013) and SMG7
(Unterholzner and Izaurralde 2004; Cho et al. 2013; Jonas
et al. 2013; Loh et al. 2013). Reduced reporter mRNA levels,
albeit to a lesser extent than observed here, were also reported
by others with SMG5-MS2 (Cho et al. 2013; Loh et al. 2013).
The same results were obtained when the MS2-fusion pro-
teins were tethered to a Renilla luciferase
reporter mRNA containing six MS2
binding sites in its 3′ UTR (Supplemental
Fig. S1). Thus, UPF1, SMG5, SMG7, and
PNRC2 can all cause a strong reduction
in reporter mRNA levels when tethered
to the 3′-UTR. Western blots were per-
formed to document the expression of
the MS2-fusion proteins in the TFA
(Fig. 1C).
SMG5-mediated reporter mRNA level
reduction requires SMG7
To examine which other factors were re-
quired for the strong reporter level re-
ductions induced by the tethered SMG5
in Figure 1B, we performed TFAs with
SMG5–MS2 in cells wherein UPF1,
SMG1, SMG6, SMG7, or PNRC2 levels
were reduced by expressing the corre-
sponding shRNAs, while expression of a
shRNA with no predicted target RNA
(Ctr KD) served as a control. Part of
the cell lysates were used to extract
RNA and determine the relative β-globin
reporter mRNA levels (Fig. 2A), while
western blots were performed with the
remainder of each lysate to assess the
knockdown efficiencies of the stipulated
factors (Fig. 2B).
Since we were not able to detect neither endogenous
PNRC2 nor overexpressed myc-tagged or MS2-tagged
PNRC2 with any of the tested anti-PNRC2 antibodies (see
Supplemental Fig. S2), we documented the effectiveness of
all of the designated RNAi-mediated knockdowns also at
the mRNA level (Supplemental Fig. S3). Expression of
PNRC2 mRNA-targeting shRNA resulted in a strong reduc-
tion of endogenous PNRC2 mRNA and efficient depletion of
exogenously expressed MS2-PNRC2 fusion protein, docu-
menting the effectiveness of our PNRC2 knockdown (Fig.
2B, compare lanes 1 and 3 to 2 and 4).
The β-globin reporter mRNA level for each experimental
condition is depicted relative to the level in cells expressing
LacZ-MS2 and normalized to GFP mRNA expressed from
a cotransfected plasmid to account for possible differences
in transfection efficiencies among the samples (Fig. 2A;
Supplemental Table S2 for P-values). The ability of tethered
SMG5-MS2 to down-regulate the reporter mRNA predomi-
nately requires SMG7 because the SMG7 knockdown com-
promised the extent of reporter mRNA reduction by
fivefold. In contrast, knockdown of UPF1 or SMG6 did not
affect the activity of SMG5-MS2, while knockdown of
SMG1 or PNRC2 very slightly compromised the SMG5-
MS2-mediated reporter mRNA decay (Fig. 2A).
FIGURE 1. Tethered SMG5, SMG7, PNRC2, and UPF1 all strongly reduce reporter mRNA levels
bypassing the need for a PTC. (A) Schematic of theMS2-tethered function assay (TFA),where pro-
tein X represents UPF1, SMG5, SMG7, or PNRC2. (B) TFA results. Relative β-globin reporter
mRNA levels, normalized to EGFPmRNA levels andwith reportermRNA levels in cells expressing
LacZ-MS2 set as 100, were determined by RT-qPCR from total RNA of HeLa cells transfected with
pcβ-globin 6xMS2bs, pEGFP (serving as a cotransfection control) and with plasmids expressing
each of the indicated proteins fused to a MS2 moiety. The mean and standard deviations (SDs)
of >4 independent experiments are indicated, wherein (∗∗) denotes P≤ 0.01 as determined by
Student’s t-tests. (C) Western blots showing the expression of MS2-PNRC2, LacZ-MS2, and
MS2-LacZ fusion proteins (left panel), the MS2-UPF1 fusion protein (middle panel), and the
MS2-SMG5 and MS2-SMG7 fusion proteins (right panel). The antibodies used are indicated at
the right of each blot. Arrows denote the correct bands while (∗) indicates unspecific bands detect-
ed with the anti-MS2 antibody. Actin or SmB/B′ served as loading controls in the western blots.
SMG5, SMG7, and PNRC2 in NMD
www.rnajournal.org 559
 Cold Spring Harbor Laboratory Press on April 23, 2018 - Published by rnajournal.cshlp.orgDownloaded from 
Since it was shown that the SMG5–SMG7 heterodimer re-
cruits the CCR4-NOT deadenylase complex via the C-termi-
nal half of SMG7 (Loh et al. 2013), we predicted that in the
TFA, SMG5-induced reporter RNA degradation would
depend on this so-called PC region of SMG7 (Fig. 3A;
Unterholzner and Izaurralde 2004). To test this, we coex-
pressed the β-globin-6xMS2bs reporter RNA, SMG5–MS2,
and RNAi-resistant versions of SMG7 (WTR, ΔCR, ΔPCR)
in cells depleted of endogenous SMG7. As before, part of
the cell lysates was used to extract RNA and determine the rel-
ative β-globin reporter mRNA levels (Fig. 3B; Supplemental
Table S3 for P-values) and the remainder of each lysate was
used for western blotting to assess the knockdown efficiency
of endogenous SMG7 and the expression levels of the
RNAi-resistant SMG7 constructs (Fig. 3C). The finding that
SMG7-WTR rescued the ability of tethered SMG5 to decrease
the reporter RNA levels to a similar extent as observed in the
control knockdown (Ctr) was expected (Fig. 3B). However,
we were initially surprised to observe that the SMG7 con-
structs lacking the C-terminal amino acids 838–1091 (ΔCR)
and even 633–1091 (ΔPCR) also rescued tethered SMG5activ-
ity, since they cannot interact with the CCR4-NOT complex
anymore (Loh et al. 2013).
We speculated that tethered SMG5 to some extent might
also down-regulate the reporter RNA through its 14-3-3
domain interacting with SMG7 and as a heterodimer recruit-
ing UPF1. Therefore, we repeated the SMG5 TFA/SMG7 res-
cue experiment in cells depleted for both, SMG7 and UPF1
(Fig. 3D,E; Supplemental Table S3 for P-values). Compared
to the control knockdowns expressing a scrambled shRNA
(lanes 1,2), UPF1 and SMG7 protein levels were reduced to
<20% and below the level of detection, respectively (lanes
3–6, Fig. 3E). This codepletion of UPF1 and SMG7 reduced
the down-regulation of the reporter RNA in response to
SMG5 tethering by 4.5-fold from 14% to 63% (Fig. 3D, com-
pare Ctr to dKD). Expression of RNAi-resistant wildtype
SMG7 completely rescued the SMG5-induced reporter
RNA down-regulation (dKDWTR), whereas the rescuing ca-
pacity of SMG7-ΔCR, although expressed to higher levels
than SMG7-WTR, was partially compromised (dKD ΔCR)
and the SMG7 lacking the entire C-terminal half did not res-
cue at all (dKD ΔPCR).
Collectively, our results demonstrate that in TFA, SMG5
induces the degradation of the reporter RNA primarily
through its interaction with SMG7 and that this RNA decay
pathway depends on the C-terminal PC region of SMG7, in
agreement with a previous study showing that this region re-
cruits the CCR4-NOT deadenylase complex (Loh et al. 2013).
Yeast two-hybrid assays confirm SMG5–SMG7
and UPF1–PNRC2 interactions but do not
identify a SMG5–PNRC2 interaction
Given our results above and the partial inconsistencies with
other studies (Cho et al. 2013),wedecided to examine the pro-
tein–protein interaction networks between UPF1, SMG5,
SMG7, and PNRC2 using yeast two-hybrid assays (Fields
and Song 1989). First, we tested the interaction of SMG7 fused
to the GAL4-activation domain (-AD) against UPF1, PNRC2,
and SMG5, all fused to the GAL4-DNA-binding domain
(-BD) (Fig. 4A). Usage of the LacZ reporter gene allowed
detection of colonies expressing β-galactosidase by addition
FIGURE 2. SMG5-mediated reporter mRNA decay requires SMG7. (A)
TFA of SMG5-MS2 as in Figure 1, except performed in cells with a
knockdown (KD) of the factors indicated at the bottom of each panel.
Ctr denotes cells expressing a control shRNA. Relative β-globin reporter
mRNA levels were normalized to EGFP mRNA levels and with mRNA
levels in cells expressing LacZ-MS2 set as 100 (dashed line). The Ctr
knockdown condition (black bar) serves as reference to assess the effects
caused by depletion of the indicated factors in the respective tethering
assays. The mean and SD of >4 independent experiments are shown.
P-values≤ 0.01 are indicated as (∗∗) and≤ 0.05 as (∗). (B) Western blots
examining the knockdown efficiencies of the NMD factors from Figure
2A. Lanes 1–3 show serial dilutions (100%, 33%, and 11%) of cell lysate
from untransfected HeLa cells (Plain cells). Lanes 4 and 5 display the
protein levels from cells expressing a control shRNA (Ctr KD) and
the shRNA targeting the designated NMD factor (KD), respectively.
The antibodies used are indicated at the right of each blot. The efficiency
of the PNRC2 knockdown assessed using an anti-MS2 antibody is doc-
umented using cells transfected with plasmids expressing either a con-
trol shRNA (Ctr KD; lanes 1 and 3) or shRNAs targeting PNRC2
(KD; lanes 2 and 4), along with the indicated amount of plasmid ex-
pressing MS2-PNRC2. Arrows represent the correct bands while the
(∗) points to unspecific bands. Detection of CPSF-73 levels served as a
loading control.
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of the chromogenic substrate X-gal to the plates. Of each
cotransformation, four colonies (A–D) were analyzed.
Coexpression of BD-UPF1 and AD-SMG7 resulted in weak
blue colonies (Fig. 4A, row 2), indicating a weak interaction
between UPF1 and SMG7.While we did not observe an inter-
action betweenBD-PNRC2andAD-SMG7 (row3), we scored
a strong blue color and hence interaction between the BD-
SMG5 and AD-SMG7 (row 4). While the observed strong in-
teractionbetweenSMG5and SMG7 is in linewith previous re-
ports (Anders et al. 2003;Ohnishi et al. 2003; Jonas et al. 2013)
we could not observe the recently documented SMG5–
PNRC2 interaction (Cho et al. 2013) in our yeast two-hybrid
assays (row 12). However, coexpression of BD-UPF1 and AD-
PNRC2 resulted in blue colonies (row 6), signifying an inter-
action between the UPF1 and PNRC2. Furthermore, by ex-
pressing UPF1 deletion mutants fused to the BD, we were
able to decipher that PNRC2 interacts
with the N-terminal first 271 amino acids
of UPF1, which comprises the cysteine-
histidine rich (CH) domain, and not
with the helicase domain (HD) or the
C-terminal serine-glutamate rich (SQ)
domain (Fig. 4A, compare rows 6–11).
The BD-only controls showed that none
of the proteins fused to the -AD were
self-activating in these assays (rows 1
and 5), and the AD-only controls con-
firmed that none of the proteins fused to
the BD were able to cause self-activation
(rows 13–16). BD-eRF3a and AD-eRF1
were included as a positive control (row
17), since the interaction between eRF1
and eRF3 is well established (Stansfield
et al. 1995; Zhouravleva et al. 1995). We
also performed the same assays with
PNRC2 and SMG7 fused to the DNA-
BD and SMG5 and UPF1 fused to the
AD and the reciprocal fusions for eRF1
and eRF3. By performing the assays with
the proteins fused to the opposite part of
the GAL4 transcription factor, we found
that SMG7 fused to the BD causes strong
self-activation (data not shown). We
could not detect an interaction between
BD-SMG5 and AD-UPF1 or between
AD-SMG5 and BD-PNRC2 but we could
confirm an interaction between AD-
UPF1 and BD-PNRC2 (Supplemental
Fig. S4A,B).
In addition to the directed yeast
two-hybrid assays described above, we
also carried out a small yeast mating
screen (Finley and Brent 1994) to exam-
ine the various interactions between
UPF1, SMG5, SMG7, PNRC2, and other
NMD factors (Supplemental Fig. S5A,B). One mating type
(MATα) expressing proteins fused to the AD was mated
with the opposite mating type (MATa) expressing proteins
fused to the BD to generate diploids that contained both con-
structs and were subsequently tested for protein–protein in-
teractions by assaying the ADE2 and theHIS3 reporter genes.
The former was done by testing for growth on medium lack-
ing adenine and the latter was performed by testing for
growth on medium lacking histidine but containing 2.5
mM 3-AT. Supplemental Figure S5 shows the results of
screens carried out using at least ten different transformants
of the designated proteins fused to the AD. Two reporter
genes were assayed for activation and all the interactions
found in ≥80% or ≥60% are indicated by dark green or light
green colored boxes, respectively. The yeast mating screen
substantiated our findings from the directed yeast two-hybrid
FIGURE 3. SMG5-MS2 requires the SMG7 PC region for reporter mRNA degradation. (A) The
SMG7 domain architecture is schematically depicted (Unterholzner and Izaurralde 2004). (B,D)
SMG5–MS2 TFAs, performed in cells with SMG7 knockdown in B or with a double SMG7/UPF1
knockdown (dKD) in D and rescuing with the indicated RNAi-resistant SMG7 constructs (WTR,
wild-type; ΔCR, lacking the C terminus; ΔPCR, lacking the whole PC region). Relative β-globin
reporter mRNA levels were normalized to EGFP mRNA levels and with mRNA levels in cells ex-
pressing LacZ-MS2 set as 100. The control knockdown conditions (black bars) serve as reference
to assess the effects of the tethered protein, the depletion of the indicated factors and the rescue
with the corresponding constructs. The mean and SD of >4 independent experiments are shown,
with P-values≤ 0.01 depicted as (∗∗). (C,E) Western blots examining the knockdown efficiencies
of the NMD factors and the protein levels of the SMG7 rescue constructs from B and D, respec-
tively. The antibodies used are indicated at the right of each blot. (C) Lanes 2–4 depict serial di-
lutions (11%, 33%, and 100%) of the control knockdown sample. (E) The unspecific band
detected with the anti-HA antibody is denoted with a (∗), and the bands corresponding to
HA-SMG5 and HA-LacZ are indicated by arrows. Detection of Actin levels served as a loading
control.
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assays in that we found interactions be-
tween AD-UPF1 and BD-PNRC2, as
well as between AD-PNRC2 and BD-
UPF1, and we could again specifically
map this interaction point to the N-ter-
minal 271 amino acids of UPF1 (Supple-
mental Fig. S5A). Furthermore, we found
that AD-PNRC2 interacted with BD-
PNRC2, opening up the possibility that
PNRC2 may function as a dimer. Again,
we could not identify any interaction be-
tween AD-PNRC2 and BD-SMG5, nor
could we score an interaction between
AD-SMG5 and BD-PNRC2. In contrast
to the directed yeast two-hybrid assays,
we detected in the mating assay the previ-
ously reported interaction between UPF1
and SMG5 with both AD-UPF1 and BD-
SMG5 as well as with AD-SMG5 and BD-
UPF1 but could not map the SMG5 in-
teraction to a specific part of UPF1, sug-
gesting that SMG5 may interact with
various domains of UPF1. For themating
assays, we always fused the desired pro-
teins to both the DNA-BD and AD, since
this allows the possibility to escape any
steric hindrances, misfolding or low ex-
pression that may occur in one particular
protein fusion constellation. Due to this,
we could identify protein fusions that
caused reporter gene self-activation and
this is the reason why the screens are
not identically reciprocal.
As described above and confirming
all of our earlier findings, we observed
again PNRC2 interacting with itself and
with UPF1, but not with SMG5, while
we scored an interaction between BD-
SMG5 and AD-SMG7 (Supplemental
Fig. S5B). Thus, the lack of detecting an
interaction between SMG5 and PNRC2
cannot be due to one or both fusion pro-
teins not expressing in the yeast cells. We
could also identify previously character-
ized UPF1 interaction partners such as
UPF2 and SMG6 (Clerici et al. 2009;
Okada-Katsuhata et al. 2012; Chakrabarti
et al. 2014; Nicholson et al. 2014), as well
as interactions between UPF1 and SMG7
and UPF1-N and SMG5, albeit with low-
er confidence.
Four conclusions can be drawn from
all of the conducted yeast two-hybrid as-
says. First, thewell-known interaction be-
tween human SMG5 and SMG7 could be
FIGURE 4. PNRC2 interacts with decapping complex factors and UPF1 but not with SMG5. (A)
Yeast two-hybrid assay. Plasmids expressing the indicated protein variants fused to the GAL4-
DNA-binding domain (BD-) were cotransformed with plasmids expressing the GAL4-activation
domain fused to SMG7 (AD-SMG7) or PNRC2 (AD-PNRC2) into Mav99 cells. The UPF1 con-
structs that were used for mapping the UPF1–PNRC2 interaction are depicted (see schematic).
Four colonies (denoted A–D) from each cotransformation were selected for the β-galactosidase
assay. BD only denotes expression of the BD alone and served to control for self-activation of
the cotransformed AD-construct (rows 1, 5, and 13). AD only represents transformation of a plas-
mid expressing GAL4-AD-empty. The known interaction between BD-eRF3 and AD-eRF1 served
as a positive control (row 17). (B,C) Schematic representation of the top ranked proteins identi-
fied by shotgun LC-MS/MS in the immunoprecipitates of SMG5–MS2 (B) or of MS2-PNRC2
(C). The diagrams were produced with Cytoscape (v3.1.1). Every protein present in the mass
spectrometry data is reported as a node that is connected with an edge to the protein used for
the immunoprecipiation (displayed as the black central node). The width of this edge is propor-
tional to the square root of the protein match score summation (PMSS) of the respective protein.
The dashed lines between proteins indicate already documented protein–protein interactions ac-
cording to the STRING data set (v9.1) with a threshold of the top 20 high confidence interactors
of every protein. Every node connected by at least one dashed line was colored in the sameway and
the legend is shown in the upper right corner. The list of proteins identified to be copurifying with
MS2-LacZ, SMG5-MS2, and MS2-PNRC2 are listed in Supplemental Tables S4–S6, respectively.
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identified for the first time by yeast two-hybrid assays. Second,
we conclude that the N-terminal 271 amino acids of UPF1 are
sufficient for its interaction with PNRC2, a region that has
also been implicated in PNRC2 interaction by coimmunopre-
cipitation assays (IPs) (Loh et al. 2013). Third, we found that
PNRC2 can bind to itself. Finally, our yeast two-hybrid assays
did not provide any evidence for an interaction between
SMG5 and PNRC2. In addition, we see evidence for potential
phosphorylation-independent interactions between SMG7,
PNRC2 and perhaps also SMG5withUPF1, sinceUPF1 phos-
phorylation most likely does not occur in yeast cells as they
lack a SMG1 ortholog (Yamashita 2013). The possibility of
SMG5 and SMG7 being able to bind UPF1 in a phosphoryla-
tion-independent manner has been previously hinted at
(Ohnishi et al. 2003; Okada-Katsuhata et al. 2012; Jonas et al.
2013) and such an interaction has been shown for SMG6 and
UPF1 to be crucial for NMD (Chakrabarti et al. 2014;
Nicholson et al. 2014).
PNRC2 interacts with decapping factors while SMG5
interacts with NMD factors
To further search for the previously reported interaction be-
tween PNRC2 and SMG5 (Cho et al. 2013) that we could
not detect in our yeast two-hybrid assays, we used a comple-
mentary approach where we immunoprecipitated MS2-
SMG5, MS2-PNRC2 and MS2-LacZ (the latter serving as a
control) from RNase A-treated cell lysates followed by shot-
gun liquid chromatography coupled to two stage mass spec-
trometry (Shotgun LC-MS/MS). The immunoprecipitated
proteins were digested on the beads with trypsin and the re-
sulting peptide mixture was directly analysed by LC-MS/
MS. Proteins that were also found copurifying with our con-
trol MS2-LacZ (Supplemental Table S4) were discarded and
an overview of the remaining proteins identified in the
MS2-SMG5 and MS2-PNRC2 IP samples are shown in
Supplemental Tables S5 and S6, respectively. We have dia-
grammatically represented in Figure 4B and C the top nine
and top 20 proteins that were found copurifying with
SMG5-MS2 orMS2-PNRC2, respectively, based on the calcu-
lated protein match score summation (PMSS).
We found theNMD factors UPF1, SMG7 andUPF2 copur-
ifying with SMG5 and notably we did not find PNRC2 (Fig.
4B). Enhancer of mRNA decapping 4 (EDC4, also known as
HEDLS or Ge-1) was the only mRNA degradation factor
copurifyingwith SMG5. Similarly, we did not find SMG5 cop-
urifying with MS2-PNRC2 (Fig. 4C). In fact, we could not
identify any bona fide NMD factors copurifying with
PNRC2. Instead, the top interactors with PNRC2 were
decapping mRNA enzyme 1A (DCP1A), DCP1B, DEAD
(Asp-Glu-Ala-Asp) box helicase 6 (DDX6, also known as
Rck/p54), enhancer of mRNA decapping 3 (EDC3) and
EDC4. Thus, we identified five well-characterized mRNA
decapping complex constituents (Houseley and Tollervey
2009; Schoenberg and Maquat 2012) copurifying with
PNRC2 which are known to also interact with each other (in-
dicated by the dashed gray line) (Ling et al. 2011). We also
found PNRC2 copurifying various important mRNA transla-
tion factors such as poly(A)-binding protein 1 (PABP1), eu-
karyotic translation initiation factor 4A1 (EIF4A1) and
eukaryotic translation elongation factor 2 (EEF2). The inter-
action of PNRC2 with various mRNA translation factors is
not surprising considering that PNRC2 seems to be an
mRNA decapping factor andmRNA translation and degrada-
tion are closely coupled (Houseley and Tollervey 2009;
Schoenberg andMaquat 2012).We also foundPNRC2 copur-
ifying with four key glycolytic enzymes which all seem towork
closely together, namely themuscle-specific pyruvate kinase 2
(PKM2), fructose-bisphosphate aldolase A (ALDOA), phos-
phoglycerate kinase 1 (PGK1), and glucose-6-phosphate
isomerase (GPI). This is interesting, since it has been reported
that PNRC2 may play a role in controlling the balance be-
tween energy storage and expenditure (Zhou et al. 2008; Lai
et al. 2012). Another interesting groupof proteins that copuri-
fiedwith PNRC2 is the heterogeneous nuclear ribonucleopro-
teins (hnRNPs). Specifically, PNRC2 copurified hnRNP C,
hnRNP E1 (also known as PCBP1), and hnRNP E2 (also
known as PCBP2).
Thus, we can summarize that in these co-IP experiments,
SMG5 primarily interacts with SMG7 and factors known to
be involved in the process of NMD, while PNRC2 chiefly in-
teracts with components of the mRNA decapping process, an
interaction that has been well documented previously (Lai
et al. 2012; Mugridge et al. 2016). Consistently, pathway anal-
ysis using the interactome analysis tool yielded NMD and 5′–
3′ exoribonucleolytic decay as the top ranked pathway for the
SMG5 and PNRC2 data sets, respectively.
PNRC2 coimmunoprecipitates primarily
phosphorylated UPF1
To gain additional information about the interactions among
the decapping complex factors DCP1A, DCP2, and PNRC2,
and of UPF1 and XRN1 with these decapping factors, we
transiently expressed pairs of tagged proteins in HEK293T
cells, immunoprecipitated one of the proteins by their re-
spective tag and checked for the copurification of the other
protein by western blotting. A first series of IPs was per-
formed with anti-MS2 antibody pulling down MS2-HA-
LacZ,MS2-UPF1, andMS2-PNRC2 (Fig. 5A–C) and in a sec-
ond series we used anti-GFP and anti-FLAG antibodies to
pull down HA-EGFP, FLAG-GAPDH, EGFP-XRN1, FLAG-
DCP1A and FLAG-DCP2 (Fig. 5D,E). MS2-HA-LacZ, HA-
GFP and FLAG-GAPDH were used as negative controls,
because they are not expected to interact with any of the test-
ed proteins.
As expected, no detectable amounts of EGFP-XRN1,
FLAG-DCP1A and FLAG-DCP2 copurified with MS2-HA-
LacZ from HEK293T cell lysates that were not treated with
RNase A (Fig. 5A, lanes 5–7). For MS2-UPF1, a very weak
SMG5, SMG7, and PNRC2 in NMD
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band that might correspond to P-UPF1,
which is the upper band of the two bands
observed in western blots with UPF1
(Flury et al. 2014), was detected in the
MS2-HA-LacZ pull-down (lane 8).
Endogenous CPSF73 served as a loading
control in the input samples and as an
additional specificity control for the IPs.
Under the same conditions, FLAG-
DCP2, but no detectable amounts of
EGFP-XRN1 and FLAG-DCP1A copuri-
fied with MS2-UPF1 (Fig. 5B). The inter-
action between UPF1 and DCP2 resisted
RNase A treatment of the lysate, indicat-
ing that it is not bridged by RNA but
rather protein–protein mediated (Fig.
5B, compare lanes 8 and 9). MS2-
PNRC2 copurified DCP1A and the phos-
phorylated form of UPF1 but no detect-
able amounts of EGFP-XRN1 (Fig. 5C).
The PNRC2 interactions with both,
DCP1A and P-UPF1, were RNase A resis-
tant (Fig. 5C, compare lanes 6 with 7 and
8 with 9). Since the proportion of copuri-
fied P-UPF1 was much higher with MS2-
PNRC2 than withMS2-HA-LacZ, in par-
ticular when taking into account the
much more efficient pull-down of MS2-
HA-LacZ compared to MS2-PNRC2,
this data suggests that PNRC2 preferen-
tially interacts with P-UPF1.
In the second series of IPs, the control
HA-EGFP did not copurify any MS2-
UPF1 or MS2-PNRC2 (Fig. 5D, lanes 5
and 6). The control FLAG-GAPDH also
did not copurify any MS2-PNRC2 (lane
8), while trace amounts of MS2-UPF1
were detected (lane 7), suggesting that
UPF1 has a slight tendency to co-IP pro-
miscuously. These control IPs were per-
formed without RNase A treatment of
the lysates to allow for the detection of
both, RNA-mediated and RNA-indepen-
dent interactions. Much higher amounts
of MS2-UPF1 than observed with the
controls copurified with EGFP-XRN1,
FLAG-DCP1A and FLAG-DCP2 in an
RNA-independent manner (Fig. 5E,
lanes 3, 4, 9, 10, 15, and 16). Notably,
FLAG-DCP1A appeared to preferentially
co-IP P-UPF1 (i.e., the uppermost of
the bands visible in the input, compare
lane 7 with lanes 9 and 10). Substantial
amounts of MS2-PNRC2 copurified
with FLAG-DCP1A regardless of RNase
FIGURE 5. UPF1 interacts with PNRC2, decapping complex factors, and XRN1, while PNRC2
coimmunoprecipitates primarily phosphorylated UPF1. (A–E) HEK293T cells were transfected
with plasmids expressing pairs of tagged proteins. Three percent of the input material and
100% of the immunoprecipitatedmaterial were loaded on to a 4%–12% gradient gel and analyzed
by SDS-PAGE. (A) As a negative control for purifying, the MS2 fusion proteinMS2-HA-LacZ was
immunoprecipitated from lysates of HEK293T cells coexpressing either EGFP-XRN1, FLAG-
DCP1A, FLAG-DCP2, or HA-UPF1 using an antibody against the MS2 coat protein. Lanes 1–4
represent the input material and lanes 5–8 show the immunoprecipitated material. (B) Lysates
from HEK293T cells coexpressing EGFP-XRN1, FLAG-DCP1A, or FLAG-DCP2 with MS2-
UPF1 and treated with RNase A (+) or untreated (−) were immunopurified using anti-MS2 an-
tibody. Lanes 1–3 represent the input material and lanes 4–9 show the immunoprecipitated ma-
terial. (C) Immunoprecipitations performed as in B from lysates of HEK293T cells expressing
MS2-PNRC2 and EGFP-XRN1, FLAG-DCP1A, or HA-UPF1. (D) As a negative control for pu-
rifying the GFP and FLAG fusion proteins, HA-EGFP and FLAG-GAPDH were purified from
HEK293T lysates cotransfected either with MS2-UPF1 or MS2-PNRC2 and using anti-GFP
and anti-FLAG antibodies, respectively. Lanes 1–4 show the input material, while lanes 5–8 rep-
resent the immunoprecipitated material. (E) GFP pull-downs from HEK293T lysates expressing
EGFP-XRN1 and MS2-UPF1 or MS2-PNRC2 (left panel), FLAG pull-downs from HEK293T ly-
sates expressing FLAG-DCP1A and MS2-UPF1 or MS2-PNRC2 (middle panel), or FLAG-DCP2
and MS2-UPF1 or MS2-PNRC2 (right panel), either treated with RNase A (+) or untreated (−).
Lanes 1–2, 7–8, and 13–14 show the input material, while lanes 3–6, 9–12, and 15–18 show the
immunoprecipitated material. CPSF73 served as a loading control for the input material and
as a negative control for the purifications. Arrows indicate the correct bands while the (∗) points
to an unspecific band detected with the anti-MS2 antibody.
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A treatment (lanes 11 and 12), as demon-
strated previously (Lai et al. 2012), while
the EGFP-XRN1 pull-down copurified
only trace amounts (lanes 5 and 6)
and FLAG-DCP2 did not bring down
any detectable amounts of MS2-PNRC2
(lanes 17 and 18). However, it should be
noted that the failure to detect PNRC2
in the DCP2 IP may be due to too little
starting material, since the lysate for this
IP appeared to contain very low amounts
of FLAG-DCP2 (lane 14). Unfortunately,
low FLAG-DCP2 expression was a recur-
rent issue in these experiments.
Collectively, these IP results are in good
agreement with our yeast two-hybrid data
(Fig. 4A), our mass spectrometry data
(Fig. 4C) and previous studies (Lykke-
Andersen 2002; Cho et al. 2009; Lai et al.
2012; Loh et al. 2013) by confirming the
interactions between preferentially phos-
phorylated UPF1 and PNRC2, between
PNRC2 and DCP1A, and between
DCP2 and UPF1 independent of UPF1’s
phosphorylation status. Furthermore,
we provide evidence for an interaction be-
tween UPF1 and XRN1, even though it
was only detected when pulling at
EGFP-XRN1 but not when pulling at
MS2-UPF1. Altogether, the results indi-
cate that P-UPF1may recruit the decapp-
ing complex to mRNA via contacts with
PNRC2 and DCP2.
Tethered UPF1 reduces reporter
mRNA levels through PNRC2 and
XRN1 but independently of the NMD
effectors SMG5, SMG6, and SMG7
Our results showing interactions be-
tween UPF1, PNRC2, decapping factors
and XRN1 raised the question as to whether in the TFA,
UPF1 might be inducing reporter mRNA degradation by di-
rect decapping of the mRNA followed by XRN1-mediated
5′–3′ exonucleolytic decay. Consistent with this hypothesis
and somewhat unexpectedly considering that UPF1 tether-
ing has been widely used as a surrogate to study the mech-
anism of NMD, tethered UPF1 did not require its
downstream NMD effectors, SMG5, SMG6, or SMG7 to re-
duce reporter mRNA levels, but instead was strongly inhib-
ited by the knockdowns of SMG1 and PNRC2 (Fig. 6A;
Supplemental Table S7 for P-values and Supplemental Fig.
S6A,B for SMG5 knockdown efficiency), suggesting that
tethered UPF1 becomes phosphorylated by SMG1 and re-
cruits the decapping complex and XRN1. Tethered
PNRC2 on the other hand did not depend on UPF1 or
SMG1 to down-regulate the reporter mRNA (Fig. 6B;
Supplemental Table S7 for P-values), which positions
PNRC2 downstream from UPF1 and SMG1 in this degrada-
tion pathway. To further delineate the mechanism by which
tethered UPF1 leads to the degradation of the reporter
mRNA, we performed additional TFAs with tethered
UPF1 or tethered PNRC2 in cells depleted for several
well-characterized mRNA degradation factors. Specifically,
we knocked down EDC4 (also known as Hedls), which is
a decapping enhancer that has been shown to promote com-
plex formation between DCP1A and DCP2 (Fenger-Gron
et al. 2005; Chang et al. 2014), XRN1, which is the major
5′–3′ exoribonuclease involved in mRNA decay (Arribas-
FIGURE 6. UPF1 and PNRC2 rely on XRN1 to induce reporter mRNA reduction in TFAs. (A)
TFA of MS2-UPF1, performed in cells with a knockdown (KD) of the factors indicated at the bot-
tom of each panel. Ctr denotes cells expressing a control shRNA. (B) TFA of MS2-PNRC2 per-
formed in cells with a UPF1 and SMG1 KD. (C) Western blots examining the knockdown
efficiencies of the indicated proteins from samples used in the experiments shown in D and E.
Lanes 1–3 show serial dilutions (100%, 33%, and 11%) of cell lysate from untransfected HeLa
cells. Lanes 4 and 5 display the protein levels from cells expressing a control shRNA (Ctr KD)
and the shRNA targeting the designated degradation factor (KD), respectively. The antibodies
used are indicated at the right of each blot and the arrow signifies the band representing
EDC4. Detection of Actin or CPSF-73 served as loading controls. (D,E) MS2-UPF1 and MS2-
PNRC2 TFAs performed in cells depleted of degradation factors. The bar chart represents the rel-
ative β-globin reporter mRNA levels under control knockdown (Ctr) conditions (black bars) and
the designated knockdown conditions (depleted factor indicated below each gray bar). The mean
and SD of >4 independent experiments are shown, with P-values≤ 0.01 depicted as (∗∗) and ≤
0.05 as (∗).
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Layton et al. 2013; Jonas et al. 2013), CNOT8 (also known
as POP2), which has 3′–5′ poly(A) exoribonuclease activity
(Collart and Panasenko 2012), and DIS3 (also known as
RRP44), which is the catalytic component of the RNA exo-
some complex and has both 3′–5′ exonuclease (Dziembow-
ski et al. 2007) as well as endonuclease (Lebreton et al. 2008;
Schaeffer et al. 2009) activities and participates in a multi-
tude of cellular RNA processing and degradation events. A
fraction of each cell lysate was used to assess the knockdown
efficiencies by western blotting (Fig. 6C). From the remain-
der of each cell lysate, we isolated total RNA and used RT-
qPCR to document the knockdowns also at the mRNA level
(Supplemental Fig. S6C–F) and to measure the β-globin re-
porter mRNA levels, which are shown relative to the level in
cells expressing LacZ-MS2 and normalized to GFP mRNA
encoded on a cotransfected expression plasmid to account
for differences in transfection efficiencies among the sam-
ples (Fig. 6D,E; Supplemental Table S7 for P-values). Our
data revealed that the reduced reporter mRNA levels in-
duced by MS2-UPF1 and MS2-PNRC2 tethering were
both dependent on XRN1. Reporter mRNA bound by
UPF1 or PNRC2 increased more than eightfold or 10-fold,
respectively, in cells depleted of XRN1, while depletion of
EDC4, CNOT8 and DIS3 did not significantly alter the
β-globin mRNA levels compared to control cells (Fig. 6D,
E). This indicates that the most dominant route of degrada-
tion induced by UPF1 artificially tethered to an mRNA is
not by recruitment of NMD factors, but rather by interact-
ing with PNRC2, which is dependent upon the presence
of XRN1.
In summary, all of our data so far suggest that tethered
UPF1 can recruit PNRC2 to induce decapping followed by
mRNA degradation by the 5′–3′ exonuclease XRN1 resulting
in the reduced reporter mRNA levels observed in the TFA.
Furthermore, since this occurs independently of SMG5,
SMG6, or SMG7, it begs the question if and how well the
UPF1 TFAmimics the process of NMD. Furthermore, the as-
sociation of PNRC2 with XRN1 and decapping factors in
conjunction with our lack of evidence for an interaction
with SMG5 challenges the previous categorization of
PNRC2 as a NMD factor.
PNRC2 seems not to be required for NMD in vivo
To directly test whether PNRC2 is needed for NMD, we
used two well-characterized NMD reporter genes, TCRβ
Ter68 and β-globin Ter39, and their respective PTC-free
control constructs (designated WT) (Thermann et al.
1998; Mühlemann et al. 2001). In these classical NMD as-
says, UPF1 knockdown led to a 10-fold increase of TCRβ
Ter68 and β-globin Ter39 mRNA, while knockdown of
PNRC2 had no effect on the mRNA levels of these two re-
porter genes (Fig. 7A,B; Supplemental Table S8 for P-values
and Supplemental Fig. S7A,B for PNRC2 and UPF1 KD ef-
ficiencies). We also examined the effect of knocking down
UPF1, SMG5, SMG6, SMG7 and PNRC2 (Supplemental
Fig. S7C,D) on the mRNA levels of the NMD reporter
gene mini-µ Ter310 (Bühler et al. 2004) and its PTC-free
version mini-µ WT (Fig. 7C,D; Supplemental Table S9 for
P-values). Depletion of UPF1 and SMG6 led to an eightfold
and 33-fold increase in mini-µ Ter310 mRNA, respectively,
while knockdown of SMG5, SMG7 or PNRC2 alone had es-
sentially no effect (Fig. 7C). Since there is evidence that in
human cells SMG6-mediated endonucleolytic cleavage acts
as the predominant mode of NMD in mammalian cells,
while SMG5–SMG7-mediated deadenylation functions on
the same target mRNAs merely as a backup system (Jonas
et al. 2013; Metze et al. 2013; Boehm et al. 2014;
Colombo et al. 2017), we reasoned that the PNRC2-depen-
dent decay pathway might also be inferior to the SMG6
pathway. Therefore, we determined mRNA levels of mini-
µ Ter310 and mini-µ WT in cells where SMG5, SMG7 or
PNRC2 was codepleted with SMG6. While codepletion of
SMG6 with SMG5 or SMG7 inhibited NMD even more or
similarly as SMG6 depletion alone, the increase of mini-µ
Ter310 mRNA observed by codepletion of PNRC2 and
SMG6 was in fact even less pronounced than in the SMG6
knockdown alone, most probably owing to the generally
less efficient knockdown efficiency of the individual factors
in the combined knockdowns. Furthermore, the combined
knockdown of PNRC2 and SMG5 resulted in the same bare-
ly significant increase of mini-µ Ter310 mRNA as knock-
down of each of these factors separately, indicating that
they seem not to be involved in a common pathway.
Finally, we wondered if PNRC2’s function in NMD might
be redundant to both the SMG6-dependent and the
SMG5–SMG7-dependent pathway and thus we performed
triple knockdowns of either SMG5, SMG6, and PNRC2,
or SMG7, SMG6, and PNRC2. In these triple knockdowns,
the mini-µ Ter310 mRNA levels increased two- to threefold
more than in the respective double knockdowns (Fig. 7C).
However, this increase was not PTC-specific and hence
not caused by NMD, since mini-µ WT mRNA levels in-
creased to a similar extent (Fig. 7D). Collectively, these re-
sults are consistent with the previously reported evidence
for a redundancy between the SMG6-dependent and the
SMG5–SMG7-dependent decay of NMD targets, and we
could not find any evidence for the specific involvement
of PNRC2 in degrading PTC-containing mRNAs, not even
when we inhibited the more dominant SMG6-dependent
mode of NMD.
Overall, we find no requirement for and thus probably no
involvement of PNRC2 in NMD in HeLa cells for three dif-
ferent NMD reporters. On the other hand, we confirmed
that UPF1, SMG6 and SMG5–SMG7 do feature in the decay
of PTC-containing reportermRNAs and that there appears to
be a hierarchy between the predominant SMG6-mediated
endonucleolytic cleavage induced mode of decay and the
less active SMG5–SMG7-mediated decay pathway, which
seems to function as a backup system.
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DISCUSSION
Using in vivo interaction mapping by yeast two-hybrid assays
and immunoprecipitation experiments combined with vari-
ous functional experiments, we investigated how SMG5,
SMG7, and PNRC2 act downstream from UPF1 to promote
the degradation of target mRNAs. Our results (Fig. 4A,B;
Supplemental Figs. S4, S5) confirm the previously demon-
strated interaction between SMG5 and
SMG7 (Jonas et al. 2013) and show that
the ability of tethered SMG5 to induce
mRNA degradation depends on SMG7
(Fig. 2A), which is consistent with a study
reporting that the C terminus of SMG7
recruits the CCR4-NOT deadenylase
complex to the mRNA via an interaction
with CNOT8 (Loh et al. 2013). Interest-
ingly, tethered SMG5 appears to be able
to induce reporter mRNA decay in two
different ways. In the presence of SMG7,
the SMG7/CCR4-NOT-dependent way
is the preferred one andUPF1 is dispensa-
ble for this pathway (Fig. 2A), while the
UPF1–PNRC2-dependent pathway (see
below) appears to be used when the
CCR4-NOT-binding C-terminal region
of SMG7 is missing (Fig. 3). Altogether,
our data in conjunction with evidence
from previous studies (Unterholzner
and Izaurralde 2004; Loh et al. 2013) sug-
gest that onemRNAdegradation pathway
activated by P-UPF1 during mammalian
NMD is the recruitment of the SMG5–
SMG7 heterodimer, which in turn leads
to SMG7-mediated recruitment of the
CCR4-NOT deadenylase complex. Fur-
thermore, such a conclusion is also con-
sistent with various early reports
suggesting that deadenylation features in
the decay of nonsense mRNAs (Chen
and Shyu 2003; Lejeune et al. 2003).
In contrast, our data are inconsistent
with a study reporting a SMG5–
PNRC2-mediated degradation pathway
in mammalian NMD, which was report-
ed to be dominant over the SMG5–
SMG7 pathway (Cho et al. 2013). We
have not been able to detect the previous-
ly described interaction between SMG5
and PNRC2, neither by yeast two-hybrid
assays nor by LC-MS/MS analysis of pro-
teins coimmunoprecipitating with SMG5
or PNRC2 (Fig. 4; Supplemental Figs. S4,
S5). Our results are in line with the pull-
down experiments performed by Loh
and colleagues who also failed to detect an interaction be-
tween SMG5 and PNRC2 (Loh et al. 2013). The association
of PNRC2 with different decapping factors in IPs (EDC3,
EDC4, DCP1A, DCP1B, and DDX6; Figs. 4B, 5) instead sug-
gests that PNRC2 is most likely a constituent of the decapping
machinery. Furthermore, in a small yeast mating screen, we
observed PNRC2 interacting with DCP1, XRN1, the DCP1/
DCP2-associated Sm-like proteins LSM1, 2 and 6 (data not
FIGURE 7. PNRC2 appears to be dispensable for NMD. (A,B) HeLa cells were transfected with
plasmids expressing either NMD insensitive WT TCRβ (A) or β-globin (B) (black bars) or their
PTC-containing counterparts (gray bars), along with pEGFP, and with plasmids expressing either
a control shRNA (Ctr) or shRNAs targeting UPF1 or PNRC2. RT-qPCR analysis was used tomea-
sure the relative TCRβ or β-globin mRNA levels, normalized to EGFP mRNA levels. The levels of
normalized NMD reporters in control knockdown cells were set to one to display fold changes.
Themean and SD of three independent experiments are shown. (C,D) HeLa cells were transfected
with plasmids expressing mini-μ Ter310 (C) or mini-μ WT (D), along with pEGFP serving as a
cotransfection control and with plasmids expressing either a control shRNA (Ctr, black bars) or
shRNAs targeting the factors specified under each gray bar. Mini-μ mRNA levels, normalized to
EGFP mRNA, were determined by RT-qPCR and are shown relative to the levels of the respective
mini-μmRNA in the control Ctr knockdown cells, which were set to one. Mean values and SD of
≥3 independent experiments are represented. In all charts, (∗∗) signifies P≤ 0.01 and (∗) denotes
P≤ 0.05 as determined by Student’s t-tests.
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shown). Similarly, Cho and colleagues have also reported
coprecipitation of DCP1A, DCP2, EDC4, and weakly of
EDC3 with PNRC2 (Cho et al. 2013). Further challenging
the reported SMG5-PNRC2-dependent decay pathway, the
down-regulation of the reporter transcript induced by teth-
ered SMG5 was not dependent on PNRC2 or UPF1 but in-
stead was dependent on SMG7 (Figs. 2A, 3). Collectively,
our data do not provide evidence for a physical or functional
association between SMG5 and PNRC2. However, we cannot
rule out that a SMG5-PNRC2-dependent mRNA degrada-
tion mode might exist in specific cell types or under specific
conditions, but even if it did, it would be unlikely to rely on a
direct interaction between PNRC2 and SMG5.
Nonetheless, this still leaves the question as to the role of
PNRC2 in the TFA and in NMD. We found PNRC2 interact-
ing with the N-terminal part of UPF1 (amino acids 1–271) in
our yeast two-hybrid assays (Fig. 4A; Supplemental Fig. S5),
which is consistent with previous pull-down experiments
demonstrating that the N-terminal conserved region (amino
acids 1–72) of UPF1 is required for this interaction (Cho et al.
2009; Loh et al. 2013). However, unlike this study, we could
not detect any requirement for the C terminus of UPF1 con-
tributing to the interaction with PNRC2 in our yeast-two hy-
brid assays, most likely because the interaction in the C
terminus of UPF1 involves phosphorylated SQ epitopes,
which probably remain unphosphorylated in yeast (Yamashi-
ta 2013). In accordance with the observed physical interac-
tion between UPF1 and PNRC2, tethered UPF1 required
PNRC2 to reduce the reporter mRNA levels in the TFA
(Fig. 6A), while tethered PNRC2 was not dependent on
UPF1 (Fig. 6B), thus positioning PNRC2 downstream from
UPF1 in this pathway. Notably, tethered UPF1 also required
SMG1 for its activity (Fig. 6A) and both, PNRC2 and DCP1A
copurified preferentially P-UPF1 (Fig. 5C,E), indicating that
UPF1 must be phosphorylated by SMG1 to function in the
TFA. Thus, our co-IP (Figs. 4C, 5) and TFA results (Fig. 6)
collectively suggest that P-UPF1 recruits the decapping com-
plex via PNRC2, which then promotes decapping of the re-
porter transcript followed by its XRN1-catalysed rapid 5′–3′
exonucleolytic degradation. The exact role of PNRC2 in hu-
man mRNA decapping is not known, but PNRC2 interacts
with DCP1A (Figs. 4C, 5C; Albers et al. 2005; Cho et al.
2009; Lai et al. 2012; Loh et al. 2013; Mugridge et al. 2016)
and this interaction has been shown to stimulate the decapp-
ing activity of DCP2 by bridging the interaction between
DCP1 and DCP2 (Lai et al. 2012), similar to EDC4, which
also has been reported to bridge the DCP1–DCP2 interaction
(Fenger-Gron et al. 2005; Chang et al. 2014). EDC4 can inter-
act with DCP1, DCP2 and XRN1 in human cells and accord-
ingly plays a pivotal role in mRNA decapping and the
coordination of decapping to 5′–3′ exonucleolytic decay by
positioning XRN1 correctly for receiving decapped mRNAs
(Braun et al. 2012; Chang et al. 2014). We have found that
tethered PNRC2 does not need EDC4 but only XRN1, and
that tethered UPF1 only requires SMG1, PNRC2 and
XRN1 to induce reporter decay (Fig. 6). Thus, it may be
that PNRC2 is also a crucial mRNA decapping enhancer
analogous to EDC4 and can act redundantly in this role
with EDC4, or perhaps PNRC2 is working together with
EDC4 since our mass spectrometry experiments detected
PNRC2 copurifying with other known mRNA decapping en-
hancers as well as with DCP1 and DCP2 (Fig. 4C).
Unexpectedly, the UPF1–PNRC2–XRN1 mRNA degrada-
tion pathway observed in the TFA was not affected by knock-
ing down SMG5, SMG6, or SMG7 (Fig. 6), raising the
question if and to which extent the mRNA degradation pro-
cess triggered by artificially tethering UPF1 to a reporter tran-
script reflects the process occurring during NMD. Therefore,
it was important to test the requirement of PNRC2 on clas-
sical PTC-containing NMD reporter transcripts in vivo.
PNRC2 knockdown, despite being as efficient as a UPF1
knockdown judged by the reduction of the respective
mRNA levels (Supplemental Fig. S7), did not significantly in-
crease the abundance of any of the three tested NMD report-
ers, while UPF1 knockdown caused an eight- to 20-fold
increase (Fig. 7). Given the previously reported redundancies
between the SMG5–SMG7-dependent and the SMG6-depen-
dent NMD pathways (Jonas et al. 2013; Metze et al. 2013;
Colombo et al. 2017), we reasoned that possibly PNRC2-me-
diated RNA decay might not have been detected because of a
similar redundancy. Therefore, we also depleted PNRC2 in
combination with SMG6. Even under these conditions, we
did not observe PNRC2 contributing to the reduction of
the mini-µ Ter310 NMD reporter levels (Fig. 7C). A
combined knockdown of PNRC2 and SMG5 also failed to
inhibit NMD of the mini-µ Ter310 reporter construct,
and the observed PNRC2-associated effect on mini-µ
mRNA levels in triple knockdowns of PNRC2–SMG5–
SMG6 or PNRC2–SMG7–SMG6 were not PTC-specific
(Fig. 7C,D). Altogether, these data indicate that PNRC2 is
not involved in NMD of the mini-µ Ter310 reporter tran-
script in HeLa cells. We cannot rule out that PNRC2 may
play a role in NMD of specific transcripts or other cell types.
Little is known concerning the function of SMG5 in NMD
and our results have only revealed a little more insight. SMG5
knockdown had only a modest effect on the tested NMD re-
porter mRNAs (Fig. 7C and data not shown), whereas it ro-
bustly diminished the reporter mRNA levels in the TFA in a
manner that was sensitive to SMG7 depletion (Figs. 2, 3). The
dimerization with SMG7 was previously documented in vitro
and by immunoprecipitation experiments (Anders et al.
2003; Ohnishi et al. 2003; Jonas et al. 2013) and here con-
firmed by yeast two-hybrid assays and mass spectrometry
analyses (Fig. 4B; Supplemental Fig. S5). Furthermore,
SMG5 coprecipitated UPF1 (Fig. 4B) and our yeast two-hy-
brid results showed that SMG5 can interact with the C termi-
nus of UPF1, where the phosphorylated sites are located, but
also hints at SMG5 alone being able to bind other parts of
UPF1, too (Supplemental Fig. S5). Thus, altogether our
data are consistent with SMG5 being an adaptor that
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facilitates the interaction between UPF1 and SMG7 during
NMD, but further work is required to fully understand the
role of SMG5 in NMD.
It has become very clear from our study that dissecting the
role of UPF1 in NMD is particularly complicated by the ev-
idence that UPF1 functions in additional cellular processes
that appear to affect mRNA stability independent from its
function in NMD (Kaygun and Marzluff 2005; Kim et al.
2005; Azzalin and Lingner 2006; Choe et al. 2014; Cho et al.
2015). The fact that UPF1 is involved in other mRNA degra-
dation events independently of the NMD machinery became
also evident in our TFAs (Fig. 6). As a consequence of UPF1’s
involvement in different RNA decay pathways, it should be
noted that documenting a requirement for UPF1 is not suf-
ficient to identify an RNA degradation pathway as NMD.
Along the same lines, physical association with UPF1 is not
sufficient to identify an mRNA as an NMD target, since re-
cent studies revealed that UPF1 initially binds most
mRNAs in the cell rather unspecifically and then selectively
releases from mRNAs that are not degraded by NMD
(Hurt et al. 2013; Zünd et al. 2013; Lee et al. 2015). The
emerging picture is that UPF1 may have a scaffolding func-
tion and can assemble a multitude of different mRNPs tai-
lored to various different degradation pathways.
In addition to the mechanistic aspects addressed here, our
work clearly illustrates the need for an unambiguous opera-
tional definition of the term “nonsense-mediated mRNA de-
cay” (NMD) in mammalian cells. Originally, this term was
used to describe the rapid degradation of mRNAs with an
open reading frame-interrupting PTC, and the key criteria
to distinguish NMD from other RNA decay pathways was
that the corresponding PTC-free transcript was not affected
(Maquat 1995). When it was later discovered that even PTC-
free mRNAs can be stabilized by inactivation of various
NMD factors in human cells (Mendell et al. 2004; Viegas
et al. 2007; Yepiskoposyan et al. 2011; Tani et al. 2012;
Celik et al. 2017; Colombo et al. 2017), the defining criteria
for NMD shifted away from cis-acting features of the target
mRNAs toward the dependence of an mRNA destabilization
event on the known trans-acting NMD factors. However, an
NMD definition relying on the requirement for a set of
trans-acting factors is problematic as it is based on the as-
sumption that only one NMD mechanism exists that re-
quires an identical set of trans-acting factors for all NMD-
targeted mRNAs. Yet, this assumption could be incorrect,
since there is evidence in mammalian systems for an EJC-
enhanced and an EJC-independent NMD pathway (Zhang
et al. 1998; Rajavel and Neufeld 2001; Delpy et al. 2004;
Bühler et al. 2006; Matsuda et al. 2007; Singh et al. 2008;
Metze et al. 2013), as well as evidence for a UPF2-indepen-
dent and a UPF3-independent pathway (Gehring et al. 2005;
Chan et al. 2007; Metze et al. 2013) and redundancy between
SMG6-dependent and SMG7-dependent NMD (Colombo
et al. 2017). It is not known if these reported heterogeneities
in mammalian NMD actually reflect the existence of multi-
ple, mechanistically distinct NMD pathways, or if there is
one common pathway with different factors being more
rate-limiting for some substrates than for others. Future
work further elucidating the spatial and temporal molecular
interactions among all known NMD factors will ultimately
reveal the long desired detailed mechanistic understanding
of NMD.
MATERIALS AND METHODS
Plasmids
The plasmids expressingMS2-UPF1 andMS2-PNRC2 are explained
elsewhere (Lykke-Andersen et al. 2000; Cho et al. 2009), respective-
ly. Plasmids encoding SMG5-MS2-HA and SMG7 (isoform 1)-
MS2-HA were generated by inserting the corresponding cDNAs
into the NheI site of pCMV-MS2-HA (Eberle et al. 2008). The
two NheI sites in the SMG5 open reading frame were abolished
by creating silent mutations using site-directed mutagenesis as de-
scribed earlier (Nicholson et al. 2012).
To generate pcDNA3-FLAG-SMG7(iso2)-RNAiR, silent muta-
tions in the region targeted by our shRNA assay were introduced
to pcDNA3-FLAG-SMG7 isoform 2 (Colombo et al. 2017) using
site mutagenesis as outlined earlier (Nicholson et al. 2012). The
plasmids encoding the SMG7 deletion constructs were generated
by PCR amplification using primer pairs introducing XhoI and
ApaI sites to nucleotides 1–2514 (ΔC) and 1–1895 (ΔPC) of
SMG7 isoform 2. The amplified constructs were then sub-cloned
into XhoI–ApaI cut pcDNA3-FLAG-SMG7(iso2)-RNAiR.
The plasmids expressing decapping factors DCP1A and DCP2
(pcDNA3-FLAG-Myc-DCP1A and pcDNA3-FLAG-Myc-DCP2, re-
spectively) and the plasmid expressing EGFP-tagged XRN1 were
previously described (Lykke-Andersen and Wagner 2005; Braun
et al. 2012). The plasmid expressing pcDNA3-HA-UPF1(isoform
2)-RNAiR was previously explained (Nicholson et al. 2014). To ob-
tain the pcDNA3-HA-EGFP plasmid, the EGFP ORF was ligated
into pcDNA3-HA downstream from the HA tag.
The plasmids expressing SMG5 and SMG7 (isoform 1) fused to
GAL4 DNA-AD were generated by PCR amplification using plas-
mids with NdeI and XhoI restriction sites and subsequent sub-clon-
ing into pCR 2.1-TOPO vector (Life Technologies). In the TOPO
vector, the NdeI site in the open reading frame of SMG7 was de-
stroyed by site-directedmutagenesis creating a silent pointmutation.
From here, the SMG5 and SMG7 cDNAs were inserted into NdeI–
XhoI cut pGADT7 (Clontech). Plasmid GADT7–UPF1 and
pGADT7–PNRC2 were made by PCR amplification using primers
with incorporated NdeI and BamHI sites, sub-cloning of the ampli-
cons into pCR 2.1-TOPO and pSC-A-amp/kan (Agilent Technolo-
gies) vectors, respectively, cut out and inserted into a NdeI–BamHI
cut pGADT7. Plasmid GBKT7–SMG5 and pGBKT7–PNRC2 were
generated by excising the SMG5 and PNRC2 fragments from the vec-
tors described above and inserting them into the NdeI–NotI or
NdeI–BamHI sites of pGBKT7 (Clontech), respectively. The
pGBKT7–SMG5 and pGADT7–SMG7 mutants were attained by in-
troducing specific point mutations in the equivalent wild-type plas-
mids using site-directedmutagenesis as described earlier (Nicholson
et al. 2012). pGBKT7–UPF1 (isoform 2) and all its derivatives have
been previously described (Nicholson et al. 2014).
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The plasmids encoding the β-globin Ter39, the TCRβ Ter68 and
the mini-µ Ter310 NMD reporter constructs are described in Ther-
mann et al. (1998), Mühlemann et al. (2001), and Bühler et al.
(2004). The oligonucleotide sequences used to create the pSUPuro
plasmids are documented in the Supplemental Information.
Tethered function, rescue, and NMD assays
Cells were seeded into six-well plates and DNA cotransfections were
carried out using Lipofectamine 2000 (Life Technologies) according
to the manufacturer’s guidelines. In all TFAs, 100 ng pEGFP-C3,
100 ng pcβ-globin-6xMS2bs and 1 µg plasmid expressing SMG5-
MS2-HA, MS2-PNRC2, MS2-UPF1 or LacZ-MS2-HA or HA-
MS2-LacZ, were used. When combined with knockdowns, an addi-
tional 400 ng of pSUPuro plasmid(s) was cotransfected. For the res-
cue assays in Figure 3, an additional 800 ng of the SMG7-WTR,
SMG7-ΔCR, or SMG7-ΔPCR constructs were cotransfected in the
respective samples. In Figure 7, 100 ng of mini-µ, TCRβ, or β-glo-
bin reporter plasmids, 100 ng pmCMV- pEGFP-C3, along with 400
ng pSUPuro plasmid were cotransfected. The remainder of the
knockdown protocol, during which protein and RNA samples
were always taken from the same sample, was as previously ex-
plained (Nicholson et al. 2012). Quantitative PCR assays are cata-
logued in the Supplemental Information section. To examine
protein levels, cell lysates corresponding to 35,000 whole-cell equiv-
alents per lane were separated on 6%–15% SDS-PAGE, and the pro-
teins were transferred to a PVDF membrane (Westran Clear Signal,
GE Healthcare) and probed with the specified primary antibodies
and appropriate fluorophore-coupled secondary antibodies.
Fluorescent signals were captured using the Odyssey Infrared
Imaging System (LI-COR Biosciences). The full directory of all an-
tibodies used in this study can be found in the Supplemental Tables
S10 and S11.
Yeast two-hybrid β-galactosidase plate assays
Two hundred and fifty nanograms of the pGADT7 and pGBKT7
plasmids were cotransformed intoMav99 cells (Vidal et al. 1996) ac-
cording to the high-efficiency LiOAc/single-stranded carrier DNA
(Clontech)/PEG method of transformation (Gietz et al. 1992),
and the yeast two hybrid β-galactosidase plate assays were performed
as described in Nicholson et al. (2014).
MS2-immunoprecipitation followed by mass
spectrometry
HeLa cells were seeded in to 10 cm dishes, and the next day cotrans-
fections with either 10 µg pCMV-SMG5-MS2-HA, pCMV-MS2-
PNRC2, or pCMV-HA-MS2-LacZ were carried out using Lipofect-
amine 2000. For the entire immunoprecipitation, gloves were worn
to minimize keratin contamination, and low protein-Lobind tubes
1.5 mL (Eppendorf) were used. Two days post transfection, the cells
were harvested and incubated at 3 × 104 cells/µL in hypotonic gentle
lysis buffer (HGLB: 10 mM Tris-HCl pH 7.5, 10 mM NaCl, 2 mM
EDTA, 0.5% Triton X-100 freshly supplemented with 2× Halt pro-
tease [Thermo Scientific] and 20 µg/mL RNase A [Sigma-Aldrich]
creating HGLB++). The lysate was centrifuged to collect the cell
debris, the cleared lysate was retained and the salt concentration
was adjusted to 150 mM NaCl. Five micrograms of anti-Enterobac-
terio Phage MS2 Coat Protein Antibody (Millipore, ABE76) was in-
cubated with the lysate at 4°C for 1.5 h. 35 µL/IP of Dynabeads
Protein G (Life Technologies) were washed twice with wash buff-
er (TBS, 0.05% Tergitol-type NP-40) and once with high salt
HGLB++ (150 mM NaCl). The antibody/lysate mixture was com-
bined with the cleared beads and incubated at 4°C for 1 h. An input
sample (3%) was taken preceding this step and afterwards, the un-
bound fraction was retained. The beads were washed once with high
salt HGLB++ and then three times with a wash buffer lacking any
detergent (10 mM Tris-HCl pH 7.5 and 150 mM NaCl). The final
wash buffer was removed, the beads were collected in a fresh tube
and the mass spectrometry procedure was performed by the Prote-
omics & Mass Spectrometry Core Facility at the University of Bern
as described in Joncourt et al. (2014), except the trypsin digestion
was performed directly on the beads. Semi-quantitative protein
abundance was assessed using the calculated protein match score
summation (PMSS). Specifically, the total protein scores were calcu-
lated by adding up all peptide z-scores belonging to the same pro-
tein. Then the PMSS values were corrected by multiplication by
the molecular weight of the native protein (considering no post-
translational modifications) as given on the EXPASY website
(www.expasy.org) and division by the number of theoretically ob-
servable peptides, which was defined as peptides following the tryp-
sin cleavage rules (C-terminal to lysine and arginine, not if proline at
P1
′ position) with zero or one missed cleavage and having a molec-
ular mass between 720 and 3000 kDa (Colinge et al. 2004). This
whole experiment was carried out twice independently.
MS2, GFP, and FLAG immunoprecipitations
HEK293T cells were seeded in to 15 cm dishes and the next day
cotransfected with 11 µg pCMV-HA-MS2-LacZ, 11 µg pCMV-
MS2-UPF1, 11 µg pCMV-MS2-HA-PNRC2, 6 µg pcDNA3-HA-
UPF1R, 6 µg pcDNA3-HA-EGFP, 26 µg pT7-EGFP-C1-HsXRN1,
3 µg pCMV6-mGADPH-myc-FLAG, 7.5 µg pcDNA3-FLAG-
Myc-DCP1A and 26 µg pcDNA3-FLAG-Myc-DCP2 in pairs ac-
cording to the schemes in Figure 5. Lipofectamine 2000 was used
for transfections and cells were harvested after 48 h. The remainder
of the immunoprecipitation protocol is as explained above with
some minor alterations or additions. Namely, 2 × 107 cells were
collected for lysis in 1 mL HGLB supplemented with 1× protease
inhibitor cocktail (Biotool), the lysates were incubated with either
4 µg of anti-MS2 (Millipore, ABE76) or 4 µg of anti-FLAG(M2),
the GFP immunoprecipitation lysates were incubated directly
with 5 µL/IP Dynabeads m270 Epoxy (Thermo Scientific) coupled
with anti-GFP, according to the manufacturer’s protocol (8 µg/mg
of beads), and where indicated, RNase A (Sigma) was added to a
final concentration of 200 µg/mL in IP wash buffer (TBS 0.05%
NP40 supplemented with protease inhibitor) and incubated at
RT for 30 min prior to elution. At the final wash step the beads
were collected in a fresh tube and eluted in 30 µL of NuPAGE
LDS sample buffer (Thermo Fisher Scientific). Protein samples
from input and immunoprecipitations (100% of the IP samples)
were incubated at 75°C for 10 min before loading on the
NuPAGE gels (Thermo Fisher Scientific). After electrophoresis,
the proteins were transferred to an Optitran BA-S 85 reinforced ni-
trocellulose membrane (Whatman GmbH), followed by immuno-
blotting as outlined above.
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